Atlas Trials

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Clinical trial NCT07622329 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07622329
Sponsor
The General Hospital of Western Theater Command
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Thrombocytopenic Purpura, Immune
Start date
2026-06-18
Primary completion
2026-08-30
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.